Annual report pursuant to Section 13 and 15(d)

Selected Balance Sheet Information

v3.20.4
Selected Balance Sheet Information
12 Months Ended
Dec. 31, 2020
Selected Balance Sheet Information  
Selected Balance Sheet Information

3. Selected Balance Sheet Information

PREPAID EXPENSES AND OTHER CURRENT ASSETS (in thousands):

 

 

 

 

 

 

 

 

 

    

December 31, 

    

December 31, 

 

 

2020

 

2019

Prepaid insurances

 

$

639

 

$

549

Prepaid clinical research organizations

 

 

470

 

 

48

Stock sales receivable

 

 

469

 

 

 3

Prepaid consulting, subscriptions and other expenses

 

 

90

 

 

134

Prepaid manufacturing expenses

 

 

39

 

 

622

Prepaid conferences and travel

 

 

 —

 

 

25

 

 

 

 

 

 

 

Total

 

$

1,707

 

$

1,381

 

Prepaid CRO expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services.

PROPERTY AND EQUIPMENT (in thousands)

 

 

 

 

 

 

 

 

 

    

December 31, 

    

December 31, 

 

 

2020

 

2019

Computers and office equipment

 

$

813

 

$

804

Leasehold improvements

 

 

439

 

 

439

Software

 

 

11

 

 

11

 

 

 

1,263

 

 

1,254

Less: accumulated depreciation and amortization

 

 

(1,089)

 

 

(887)

 

 

 

  

 

 

  

Total

 

$

174

 

$

367

 

ACCRUED EXPENSES (in thousands)

 

 

 

 

 

 

 

 

 

    

December 31, 

    

December 31, 

 

 

2020

 

2019

Accrued clinical consulting services

 

$

700

 

$

684

Accrued vendor payments

 

 

225

 

 

456

Accrued manufacturing costs

 

 

 —

 

 

636

 

 

 

  

 

 

  

Total

 

$

925

 

$

1,776

 

ACCRUED EMPLOYEE BENEFITS (in thousands)

 

 

 

 

 

 

 

 

 

    

December 31, 

    

December 31, 

 

 

2020

 

2019

Accrued bonus expense

 

$

724

 

$

858

Accrued vacation expense

 

 

144

 

 

77

 

 

 

  

 

 

  

Total

 

$

868

 

$

935